Tigecycline-induced pancreatitis (n = 21) Non-pancreatitis (n = 3720)
P value
OR (95% CI)
P value
Age (years), median (IQR) 48.0 (36.5–58.5) 54.0 (44.0–65.0) .072* 0.977 (0.949–1.006) .116
Length of hospital stay (days), median (IQR) 30.0 (25.0–43.5) 25.0 (17.0–37.0) .024** 1.009 (0.997–1.021) .157
Renal insufficiency, n (%) 7 (33.3) 579 (15.6) .025** 3.032 (1.193–7.707) .020**
Multiple organ failure, n (%) 3 (14.3) 196 (5.3) .066* 1.026 (0.227–4.641) .974
Alkaline phosphatase (U/L), median (IQR) 104.0 (76.0–129.5) 82.0 (61–116.8) .017** 1.002 (1.000–1.004) .070
Prothrombin time (s), median (IQR) 14.1 (13.2–15.1) 14.8 (13.8–16.2) .053* 0.814 (0.605–1.093) .171
Activated partial thromboplastin time (s), median (IQR) 36.8 (35.2–42.5) 41.2 (36.6–46.9) .072* 0.974 (0.910–1.044) .458